Pantoprazole vs omeprazole safety
Pro Research Analysisby 
Searched over 200M research papers
Safety Profile Comparison: Pantoprazole vs Omeprazole
Both pantoprazole and omeprazole are proton pump inhibitors (PPIs) widely used for acid-related diseases. Multiple studies have found that both drugs are generally well tolerated and have similar safety profiles, with no serious drug-related adverse events reported in short-term or long-term use for conditions like reflux esophagitis, gastric and duodenal ulcers, and for the prevention of NSAID-associated gastrointestinal lesions 1368.
Adverse Events and Tolerability
Clinical trials and real-world studies consistently show that both pantoprazole and omeprazole are safe, with very few adverse events reported. In studies involving patients with gastroesophageal reflux disease (GERD), duodenal and gastric ulcers, and those taking NSAIDs, both medications were well tolerated, and no significant differences in adverse event rates were observed 1236+1 MORE. Even in patients with comorbidities such as hypertension, diabetes, or cardiac conditions, both drugs were found to be safe .
Cardiovascular and Platelet Safety
Research examining the cardiovascular safety of pantoprazole and omeprazole found no effect on blood pressure, heart rate, or electrocardiogram readings, even at doses much higher than those used clinically . Additionally, in patients with acute coronary syndrome receiving clopidogrel, neither pantoprazole nor omeprazole increased the risk of adverse clinical events or interfered with platelet function .
Long-Term Safety and Special Populations
Long-term safety data indicate that pantoprazole and omeprazole have similar safety profiles, including in populations at higher risk, such as elderly patients on chronic NSAID therapy and kidney transplant recipients 6810. However, one study suggested that pantoprazole may be associated with a lower risk of iron deficiency compared to omeprazole, especially at lower doses, though further research is needed to confirm this finding .
Conclusion
Pantoprazole and omeprazole are both safe and well-tolerated options for the treatment of acid-related diseases. They have similar safety profiles, with no significant differences in the incidence of adverse events, cardiovascular effects, or drug interactions in most patient groups. Some evidence suggests pantoprazole may have a slight advantage regarding iron deficiency risk, but overall, both medications are considered safe choices for most patients.
Sources and full results
Most relevant research papers on this topic